Trial intelligence / Profile preview

Botox for Pain in Advanced Parkinson's Disease

NCT02472210Phase 4Unknown

Sponsor
University Health Network
Start
Jul 2014
Primary completion
Jul 2015
Modality
Recombinant Proteins and Enzymes
01

Overview

A Phase 4 trial of botulinum toxin type A in Parkinson's disease (PD), sponsored by University Health Network. Status: unknown.

02

Drugs

botulinum toxin type A
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT02472210.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02472210.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call